Healthcare system transformation by genomic newborn screening
Early pilot studies of genomic newborn screening demonstrate acceptability and feasibility.
Expanding this to population scale for public health programmes requires a system shift from reactive healthcare to preventive healthcare. 4
Data management and reuse to optimize the value of genomic data to the individuals and the healthcare system will require substantial technological innovation and the development of ethics and policy frameworks.
A transdisciplinary, global approach is likely to accelerate evidence generation and will be essential to address issues of health equity.
https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(26)00218-2
